Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9034 USD | +0.87% | -6.52% | -34.54% |
Financials (USD)
Sales 2023 * | 37.41M | Sales 2024 * | 140M | Capitalization | 174M |
---|---|---|---|---|---|
Net income 2023 * | -199M | Net income 2024 * | -241M | EV / Sales 2023 * | -1.78 x |
Net cash position 2023 * | 241M | Net cash position 2024 * | 106M | EV / Sales 2024 * | 0.49 x |
P/E ratio 2023 * |
-0.54
x | P/E ratio 2024 * |
-0.56
x | Employees | 323 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 99.62% |
Latest transcript on bluebird bio, Inc.
1 day | +0.87% | ||
1 week | -6.52% | ||
1 month | +1.84% | ||
3 months | -35.01% | ||
6 months | -76.35% | ||
Current year | -34.54% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Obenshain
CEO | Chief Executive Officer | 51 | 15-12-31 |
Director of Finance/CFO | 51 | 22-11-06 | |
Melissa Bonner
CTO | Chief Tech/Sci/R&D Officer | - | 21-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Vachon
CHM | Chairman | 65 | 14-07-15 |
Nick Leschly
BRD | Director/Board Member | 51 | 10-02-28 |
Richard Paulson
BRD | Director/Board Member | 56 | 23-04-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.47% | 14 M€ | -5.07% | ||
0.11% | 234 M€ | +8.48% | - | |
0.10% | 12 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.9034 | +0.87% | 4,173,069 |
24-05-30 | 0.8956 | -0.64% | 5,901,237 |
24-05-29 | 0.9014 | -4.12% | 7,386,482 |
24-05-28 | 0.9401 | -2.72% | 4,786,745 |
24-05-24 | 0.9664 | -0.29% | 3,300,354 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.54% | 174M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- BLUE Stock